Central African Republic vs Indonesia: Hypertension effective treatment coverage (controlled hypertension)
Central African Republic
5.6%
in 2019
Indonesia
4.4%
in 2019
Central African Republic rank
191st
Indonesia rank
193rd
Hypertension effective treatment coverage (controlled hypertension) over time
- Central African Republic
- Indonesia
How they compare
Central African Republic currently reports 5.6% against 4.4% in Indonesia, a difference of 1.2%.
That makes Central African Republic's figure about 1.3 times Indonesia's.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Central African Republic ahead.
Central African Republic ranks 191st and Indonesia ranks 193rd of 193 countries.
Across the 3 decades both report, Central African Republic averaged higher in 2 and Indonesia in 1.
Head to head by decade
| Decade | Central African Republic | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.4% | 0.9% | 0.5% | Central African Republic |
| 2000s | 2.2% | 2.2% | 0.0% | Indonesia |
| 2010s | 4.2% | 4.0% | 0.1% | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Central African Republic or Indonesia?
- Central African Republic, at 5.6% against 4.4% in Indonesia as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Central African Republic and Indonesia?
- 1.2%, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Indonesia?
- 30 years are reported by both, from 1990 to 2019.
- How do Central African Republic and Indonesia rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Central African Republic ranks 191st and Indonesia ranks 193rd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.